Molly Rad, MD
Specialist · Los Altos
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 3
- 2 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rad’s office at (650) 864-0000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A53648 · Current
Licensed to practise in California · since 1994 · expires 2028-08-31 · Tehran University of Medical Sciences and Health Services.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$2,233 in 2023
Medicaid paid $2,233 for 77 billed services this clinician did in 2023, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 31 | $1,354 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 15 | $536 |
| Screening test, pure tone, air only | 31 | $344 |
| 2023 | 77 | 3 | 19 | $2,233 |
| 2022 | 164 | 5 | 15 | $5,345 |
| 2021 | 330 | 6 | 24 | $6,199 |
| 2020 | 313 | 6 | 35 | $6,294 |
| 2019 | 411 | 5 | 30 | $7,963 |
| 2018 | 350 | 5 | 32 | $5,670 |
See the largest Medicaid services in earlier years
2022
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 71 | $3,190 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 28 | $908 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 15 | $577 |
| Pure tone audiometry (threshold); air only | 25 | $375 |
| Screening test, pure tone, air only | 25 | $294 |
2021
| Pure tone audiometry (threshold); air only | 154 | $2,002 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 62 | $1,904 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 34 | $907 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 15 | $725 |
| Screening test, pure tone, air only | 38 | $416 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 27 | $245 |
2020
| Pure tone audiometry (threshold); air only | 189 | $2,595 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 37 | $1,595 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 33 | $1,072 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 17 | $618 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 24 | $255 |
| Screening test, pure tone, air only | 13 | $160 |
2019
| Pure tone audiometry (threshold); air only | 286 | $4,185 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 61 | $1,937 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 28 | $872 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 16 | $773 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 20 | $195 |
2018
| Pure tone audiometry (threshold); air only | 276 | $4,020 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 27 | $989 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 14 | $472 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 21 | $188 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 12 | $0 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 17 Part D prescriptions in 2016. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$220 in 2025
| 2025 | 3 | 6 | None | $220 |
| 2024 | 4 | 5 | None | $107 |
| 2023 | 3 | 4 | None | $75 |
| 2022 | 2 | 2 | None | $44 |
| 2021 | 1 | 4 | None | $120 |
| 2019 | 3 | 3 | None | $128 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Penmenvy | $187 | 4 payments
|
| Merck Sharp & Dohme | Proquad | $16 | 1 payment
|
| ALK-Abello | Neffy | $16 | 1 payment
|
See all 6 published payments
| GlaxoSmithKline | Meals · 2025-10-10 | Penmenvy | $33 |
| GlaxoSmithKline | Meals · 2025-09-16 | Penmenvy | $122 |
| ALK-Abello | Meals · 2025-07-25 | Neffy | $16 |
| GlaxoSmithKline | Meals · 2025-06-13 | Bexsero | $28 |
| GlaxoSmithKline | Meals · 2025-06-12 | Bexsero | $4 |
| Merck Sharp & Dohme | Meals · 2025-03-24 | Proquad | $16 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $107
| Pfizer | Penbraya | $37 | 2 payments
|
| Sanofi Pasteur | Vaxelis | $27 | 1 payment
|
| GlaxoSmithKline | Bexsero | $25 | 1 payment
|
| Merck Sharp & Dohme | Gardasil | $18 | 1 payment
|
2023: $75
| Merck Sharp & Dohme | Vaxelis | $34 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Flumist Quadrivalent | $22 | 1 payment
|
| Sanofi Pasteur | Fluzone Quadrivalent Northern Hemisphere | $19 | 1 payment
|
2022: $44
| Sanofi Pasteur | Menquadfi | $32 | 1 payment
|
| Pfizer | Prevnar 13 | $12 | 1 payment
|
2021: $120
| Pfizer | Prevnar 13 | $120 | 4 payments
|
2019: $128
| Pfizer | Eucrisa | $99 | 1 payment
|
| Merck Sharp & Dohme | Rotateq | $16 | 1 payment
|
| Arbor Pharmaceuticals | Otovel | $14 | 1 payment
|
Professional record
- NPI
- 1902839152
- Licence
- CA A53648California A53648: Current · expires 2028-08-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 763 Altos Oaks Dr, Suite 4, Los Altos, CA, 94024
- NPI first listed
- 2006-07-09
- NPI last updated
- 2009-12-23
This is when the NPI record was last certified, not a medical board exam.